m3wldycl | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/m3wldycl_hasAnnotation_C0559546>
?:creator	<https://research.tib.eu/covid-19/entity/Wang%2C_Yong%3B_Mao%2C_Qing%3B_Zhou%2C_Xiangdong>
?:doi	<https://research.tib.eu/covid-19/entity/10.1073/pnas.2009961117>
?:doi	10.1073/pnas.2009961117
?:journal	Proc_Natl_Acad_Sci_U_S_A
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/9eeafa33af631fabf6fa38d3f22d1d9554935481.json
?:pmc_json_files	document_parses/pmc_json/PMC7733850.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7733850>
?:pmid	<https://research.tib.eu/covid-19/entity/33203671.0>
?:pmid	33203671.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/9eeafa33af631fabf6fa38d3f22d1d9554935481>
?:source	Medline; PMC
?:title	Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-08

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/m3wldycl>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/m3wldycl>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all